[External Validation of Carbapenem-Resistant Enterobacteriaceae Acquisition Risk Prediction Model in a Medium Sized

Su Min Seo1, Ihn Sook Jeong2

  • 1Infection Control Unit, Dongeui Medical Center, Busan, Korea.

Abstract

Insights

The carbapenem-resistant Enterobacteriaceae (CRE) prediction model showed low accuracy in a medium-sized hospital. Adjusting the model’s predictors improved its performance, suggesting careful implementation is needed.

Area of Science:

  • Infectious Diseases
  • Epidemiology
  • Healthcare Quality

Background:

  • Carbapenem-resistant Enterobacteriaceae (CRE) poses a significant threat in healthcare settings.
  • Accurate prediction models are crucial for controlling CRE transmission.
  • External validation of existing models is essential to ensure their generalizability.

Purpose of the Study:

  • To evaluate the external validity of the carbapenem-resistant Enterobacteriaceae (CRE) acquisition risk prediction model (CREP-model).
  • To assess the CREP-model's performance in a medium-sized hospital setting.
  • To determine if adjustments to the model could improve its clinical utility.

Main Methods:

  • Retrospective cohort study of 613 intensive care unit patients.
  • Analysis included calibration, discrimination, and clinical usefulness of the CREP-model.
  • Model performance was assessed before and after adjusting predictor cutting points.

Main Results:

  • The CREP-model demonstrated low discrimination and clinical usefulness in the studied hospital.
  • Calibration slope was 0.87 and concordance statistic was 0.71.
  • Adjusting predictor cutting points improved the concordance statistic to 0.84 and sensitivity to 75.4%.

Conclusions:

  • The CREP-model's external validity is limited in medium-sized hospitals.
  • Adjusting predictor cutting points can enhance the model's performance and clinical usefulness.
  • Healthcare institutions should carefully assess and adapt the CREP-model before implementation.